Top Clinical Trials companies in Germany by EPS (Diluted)
This ranking features the top 7 Clinical Trials companies in Germany ranked by EPS (Diluted), averaging a EPS (Diluted) of USD 0.59, for February 06, 2025.
Germany
Clinical Trials
EPS (Diluted)
# |
Name |
EPS (Diluted) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 5.21
|
Dec. 31, 2023 | USD 55.66 | 3.14% |
|
Germany |
|
| 2 |
USD 3.54
|
Dec. 31, 2023 | USD 42.86 | 0.25% |
|
Germany |
|
| 3 |
USD -0.25
|
Dec. 31, 2023 | USD 1.55 | -3.12% |
|
Germany |
|
| 4 |
USD -0.48
|
Nov. 30, 2023 | USD 2.56 | 1.91% |
|
Germany |
|
| 5 |
USD -0.86
|
Dec. 31, 2023 | USD 2.41 | 1.69% |
|
Germany |
|
| 6 |
USD -1.32
|
Dec. 31, 2023 | USD 5.47 | 1.30% |
|
Germany |
|
| 7 |
USD -1.68
|
Dec. 31, 2023 | USD 7.30 | 4.29% |
|
Germany |
Frequently Asked Questions
-
Which Clinical Trials company in Germany has the highest EPS (Diluted) ?
The Clinical Trials company in Germany with the highest EPS (Diluted) is Formycon AG (XETRA: FYB.DE) at USD 5.21.
-
Which Clinical Trials company in Germany has the lowest EPS (Diluted) ?
The Clinical Trials company in Germany with the lowest EPS (Diluted) is Mainz Biomed B.V. (NasdaqCM: MYNZ) at USD -1.68.
-
What are the top 10 Clinical Trials companies in Germany by EPS (Diluted) ?
The top 10 Clinical Trials companies in Germany by EPS (Diluted) are Formycon AG, Biotest AG, Atai Life Sciences N.V., Heidelberg Pharma AG, InflaRx N.V., Immatics N.V. and Mainz Biomed B.V..
-
What are the bottom 10 Clinical Trials companies in Germany by EPS (Diluted) ?
The bottom 10 Clinical Trials companies in Germany by EPS (Diluted) are Mainz Biomed B.V., Immatics N.V., InflaRx N.V., Heidelberg Pharma AG, Atai Life Sciences N.V., Biotest AG and Formycon AG.
